ARCHIVES

Includes 8-page April 2002 Business & Regulatory Report.

This article is from The Cancer Letter archive.

Vol. 28 No. 18 | May 3, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Markup Of Cancer Act Renewal Bill Oct. 31; Garfinkel New ACS VP For Epidemiology

October 19, 1979

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000